GAVI announced that Julian Lob-Levyt will step down as CEO of the GAVI Alliance in October “to take up a major role in the private sector after leading the public-private global health partnership through nearly six years of growth and innovation.” Dr Lob-Levyt will continue as CEO until October to oversee GAVI’s first Resource Mobilisation Meeting on 6 October at which “existing and potential donors will be asked to pledge additional funds to enable new vaccines against pneumococcal disease and rotavirus diarrhoea to be added to immunisation programmes.” In November, Dr Lob-Levyt, will become Managing Director of DAI Europe and Senior Vice President of DAI, based in London. DAI “has worked in 150 developing and transition countries, providing comprehensive development solutions in areas including HIV/AIDS and avian influenza control, crisis mitigation and stability operations, agriculture and agribusiness, democratic governance and public sector management, private sector development and financial services, economics and trade, water and natural resources management, and energy and climate change.”

Geneva, 11 August 2010: More at: http://www.gavialliance.org/media_centre/press_releases/ceo.php